Feature | September 03, 2008| Dave Fornell

An Introduction to Embolic Protection Devices

The use of embolic protection devices (EPD) during percutaneous cardiac procedures has helped reduce the number of complications due to debris being released into the bloodstream and causing blockages in smaller vessels. The devices are designed to capture and remove debris that may be dislodged during procedures.

There are three classes of EPD devices:

1. Distal occlusion devices use a balloon catheter to temporarily block the flow of blood in a vessel while the intervention is performed. Any debris trapped in a stagnant column of blood can be removed through an aspiration catheter prior to the distal occlusion being released. Experts say one disadvantage of distal occlusion is that the end organ is ischemic during the time the device is in use. This means use of these devices requires quick action by the interventional team to complete a procedure in four to six minutes so blood flow can be restored.

2. Distal filters have a small net, referred to as a “basket,” which is supported by an expandable metal. The device allows blood to continue circulating through the pores of the filter. These filters can be used for up to five to 10 minutes, buying additional time for a procedure.

Most devices have filter pore sizes of around 100 microns. In comparison, a white blood cell measures about 25 microns. Devices that use a nitinol metal mesh filter only tend to let bigger particles through, up to about 150 microns in size. Experts say pores smaller than 100 microns can easily become clogged with platelets.

Distal filters also allow for contrast media injection during the procedure for lesion and arterial visualization.
At the beginning of the procedure the filter is constrained inside a delivery sheath, which the physician guides into position past the area of blockage to be treated. Once in place, the constraint is released and the filter pops open into position. If plaque or blood clots are dislodged during the procedure, the filter will catch them to prevent the emboli from traveling downstream, reducing the chance of an event such as a heart attack. At the end of the procedure the filter containing debris is captured in a retrieval sheath and removed from the patient’s body.

The diameter of the catheters used in placement and retrieval of the protection devices are referred to as the product’s profile.

3. Proximal occlusion devices interrupt the flow of blood upstream of the blockage. Proximal occlusion balloons are placed before the lesion is accessed and are the only type of device that allows crossing of the stenosis under protection.
Physicians say the key factors in choosing EPDs are their ability to maintain perfusion, be effective in capturing emboli, a low profile, deliverability, retractibility and the ability to recover all the debris collected.

Visualization of the protection device using imaging techniques is important because the device may not be seated well in the vessel, which could allow debris to flow around it. This may take views from multiple angles to determine proper positioning. Clinicians can also check to make sure the protection device is situated in the right location.

Experts say prolonged use of distal embolic protection devices can be associated with slow-flow or no-flow, particularly with soft, large plaques. Rapid deployment of an EPD and execution of a procedure by an experienced staff is critical to improving patient outcomes, physicians say.

While most EPDs are cleared by the FDA for coronary saphenous vein grafts interventions and carotid artery stenting, doctors frequently use them for off-label percutaneous procedures to protect patients from embolisms.

Related Content

Boston Scientific Closes Claret Medical Acquisition, Announces Positive Reimbursement Decision
News | Embolic Protection Devices | August 03, 2018
Boston Scientific Corp. announced it has recently closed its acquisition of Claret Medical Inc., a privately-held...
Claret's FDA-cleared Sentinel Cerebral Embolic Protection System for TAVR will expand Boston Scientific's structural heart portfolio. It collects emboli knocked loose that would otherwise lodge in the brain and potentially cause a stroke.

Claret's FDA-cleared Sentinel Cerebral Embolic Protection System for TAVR will expand Boston Scientific's structural heart portfolio. It collects emboli knocked loose that would otherwise lodge in the brain and potentially cause a stroke. 

News | Embolic Protection Devices | July 20, 2018
July 20, 2018 — Boston Scientific Corp.
The Emboliner Embolic Protection Catheteris designed to capture debris released from the valve and vessel walls during transcatheter aortic valve replacement (TAVR) procedures.

The Emboliner Embolic Protection Catheter is designed to capture debris released from the valve and vessel walls during transcatheter aortic valve replacement (TAVR) procedures. It allows for the passage of other catheters during TAVR procedures. 

News | Embolic Protection Devices | June 07, 2018
June 7, 2018 — The first clinical cases have been completed where the Emboliner...
Sentinel Cerebral Protection System Reduces TAVR Strokes More Than 60 Percent
News | Embolic Protection Devices | May 08, 2018
May 8, 2018 — One-year results from the Sentinel Cerebral Protection System show it can reduce the incidence of...
Emboline Inc. Completes Funding for TAVR Embolic Protection Trial
News | Embolic Protection Devices | April 20, 2018
Emerging medical device company Emboline Inc. announced it has completed a Series B funding round totaling over $10...
Sentinel Cerebral Protection System Reaches 50-Center Adoption Milestone in U.S.
News | Embolic Protection Devices | February 19, 2018
Claret Medical announced that since U.S. Food and Drug Administration (FDA) clearance in June 2017, its Sentinel...
The Boston Scientific FilterWire EZ embolic protec filter system.

The Boston Scientific FilterWire EZ embolic protection system.

News | Embolic Protection Devices | October 31, 2017
October 31, 2017 — The VAMPIRE 3 study evaluated if the selective use of distal filter protection might decrease the
Claret Medical Closes $14.5 Million in Series C Financing for Sentinel Cerebral Protection System
News | Embolic Protection Devices | October 23, 2017
October 23, 2017 — Claret Medical announced that it has closed on a Series C financing of $14.5 million led by Lights
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices | September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices | September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
Overlay Init